Adriana Hung, MD, MPH - APOL1 Mediated Kidney Disease: Toward Precision Medicine Approaches

APOL1 & Kidney Disease: Progress Toward Precision Medicine | DoM Grand Rounds | 30 March 2022Подробнее

Protective effect of variant p.N264K in the APOL1 gene against APOL1 medicated kidney disease (AMKD)Подробнее

APOL1 - A Story from Bench to BedsideПодробнее

Daniel Watford, MD, MPH - APOL1 Kidney Risk Variants and the APOLLO StudyПодробнее

Plenary Presentation - Towards Precision Medicine in Chronic Kidney DiseaseПодробнее

Metabolic Interventions in PAH- Anna Hemnes, MDПодробнее

Precision medicine @ Renal Research InstituteПодробнее

Meet the KPMP: Sushrut (Sus) Waikar, MD, MPH (Brigham and Women's Hospital)Подробнее

"Cardio-renal Risk Reduction Across the Spectrum of Type 2 DM" presented by Anip BansalПодробнее

Living with APOL1-mediated kidney disease: Dr. Kendra Richardson’s story | Vertex PharmaceuticalsПодробнее

APOL1-Mediated Kidney DiseaseПодробнее

An Introduction to the State of Kidney Precision MedicineПодробнее

J. Ashley Jefferson, MD - APOL1 Mediated Kidney DiseaseПодробнее

Advances in APOL1 TherapeuticsПодробнее

AI Revolution in Healthcare How Artificial Intelligence is Transforming MedicineПодробнее

Amanda Gomes, MD | NephrologyПодробнее

Health Tip: What is precision medicine?Подробнее

APOL1-mediated kidney disease | Rare Kidney Disease | AKFПодробнее